Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Selegilan hydrochloride tablets (midopyridine)

Early Parkinson's disease. Combined with levodopa or levodopa and peripheral dobba decarboxylase inhibitor. Combined with levodopa, it is especially suitable for the treatment of cases with motor fluctuation, such as the agent does not fluctuate due to the treatment of high-dose levodopa. More role
App download minus 10 yuan
Common name:
Selegiline Hydrochloride Tablets
Product No.:
B14202069607
Approval No.:
H20160342 (original h20110397) (inquired by the State Drug Administration)
Jianke price:
¥437.50
Product specification:
5mg*100s
Manufacturer:
Orion Corporation (Finland)
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
  • Product introduction
  • instructions
  • Qualification certificate
  • Relevant information
Product name Selegilan hydrochloride tablets (midopyridine)
Main raw materials The main component of this product is selegilan hydrochloride.
Main role Early Parkinson's disease. Combined with levodopa or levodopa and peripheral dobba decarboxylase inhibitor. Combined with levodopa, it is especially suitable for the treatment of cases with motor fluctuation, such as the agent does not fluctuate due to the treatment of high-dose levodopa.
Product specification 5mg*100s
Usage and dosage It is suitable for the treatment of early Parkinson's disease alone or combined with levodopa / peripheral Doba decarboxylase inhibitor. The starting dose of the two drugs is 5 mg. Take them in the morning, and the dose can be increased to 10 mg / day (once in the morning or twice separately). If the patient has side effects similar to levodopa when using levodopa preparation, the dose of levodopa should be reduced.
manufacturing enterprise Orion Corporation (Finland)
Jianke commitment
  • Genuine guarantee, formal invoice

    Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

  • Private packaging, privacy protection

    When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

  • Efficient logistics and safe arrival

    All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

  • Three warehouses to ensure inventory

    Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

[drug name] Selegilan hydrochloride tablets (midopyridine)

[common name] Selegiline Hydrochloride Tablets

[specification and model] 5mg*100s

[manufacturer] Orion Corporation (Finland)

[drug type] Western medicine

[approval No.] H20160342 (original h20110397)

[validity period] 36 months

[functional indications] Early Parkinson's disease. Combined with levodopa or levodopa and peripheral dobba decarboxylase inhibitor. Combined with levodopa, it is especially suitable for the treatment of cases with motor fluctuation, such as the agent does not fluctuate due to the treatment of high-dose levodopa.

[usage and dosage] It is suitable for the treatment of early Parkinson's disease alone or combined with levodopa / peripheral Doba decarboxylase inhibitor. The starting dose of the two drugs is 5 mg. Take them in the morning, and the dose can be increased to 10 mg / day (once in the morning or twice separately). If the patient has side effects similar to levodopa when using levodopa preparation, the dose of levodopa should be reduced.

[adverse reactions] The drug alone is well tolerated. It has been reported that the incidence of dry mouth, transient increase of serum aminotransferase and sleep disorders (such as insomnia) in patients taking this drug is higher than that in patients taking placebo. Since this drug can increase the effect of levodopa, the side effects of levodopa will also increase. Patients who have taken the maximum tolerated dose of levodopa may have involuntary movement, nausea, agitation, confusion, hallucination, headache, postural hypotension and vertigo, dysuria and rash when they are treated with this drug. Therefore, the potential side effects should be monitored. When this drug is added, the dose of levodopa should be reduced by an average of 30%.

[precautions] Special attention should be paid to patients with gastric and duodenal ulcer, unstable hypertension, arrhythmia, severe angina pectoris or mental illness. If you take an excessive dose (more than 30 mg per day), the selectivity of inhibiting monoamine oxidase B receptor (MAO-B) will disappear, and the inhibition of monoamine oxidase A receptor (MAO-A) will begin to increase significantly. Therefore, taking large doses of this drug and foods containing high tyramine may cause hypertension. For pregnant and lactating women, the safety of taking this drug during pregnancy and lactation has not been determined, so it is not recommended for pregnant and lactating women. Athletes should use it with caution. Please read the instructions carefully and follow the doctor's advice.

[taboo] It is forbidden for those who are allergic to the ingredients of this medicine.

[listing Permit Holder] Orion Corporation (Finland)

[packaging unit] box

[main ingredients] The main component of this product is selegilan hydrochloride.

[character] This product is white or near white crystalline powder, round, convex, 6mm in diameter.

[applicable population] unlimited

[medication for pregnant and lactating women] Not yet clear.

[medication for children] Not yet clear.

[medication for elderly patients] Not yet clear.

[storage] seal up. Keep in the shade.

Praise degree

zero%

    reminder

    Dear customer:

    In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

    Selegilan hydrochloride tablets (midopyridine)

    ¥437.50

    reminder

    To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

    Please enter the correct verification code!
    Loding...
    Can't see clearly. Change one

    Dear customer:

    Your callback failed this time. Please re-enter the verification code to try. Thank you!